Boao International Medical Center
Liver cancer treatment cost in China runs from $6,200 to $10,500 for chemoembolization of the liver, while definitive surgical removal of liver cancer ranges from $21,500 to $48,500. Total expenses depend on the cancer stage, hospital accreditation, and the specific technology utilized, such as robotic-assisted systems. International patients typically save 80-85% compared to the United States. Major treatment hubs include Beijing, Shanghai, and Guangzhou.
Typical Liver Cancer Treatment Costs in China
Bookimed Expert Insight: Advanced-stage patients find significant value in Guangzhou at Fuda Cancer Hospital. They specialize in minimally invasive NanoKnife and cryosurgery for complex cases. Dr. Niu Lizhi has performed nearly 10,000 cryosurgeries, offering deep expertise for non-surgical candidates. For precision radiotherapy, Xiamen Humanity Hospital provides tertiary-level care with multidisciplinary oncological support. These JCI-accredited clinics serve international patients from over 100 countries effectively.
| China | Turkey | Austria | |
| Tomotherapy | from $17,500 | from $12,000 | from $30,000 |
| Removal of liver cancer | from $21,500 | from $10,800 | from $40,000 |
| Radiofrequency ablation of the liver | from $5,500 | from $3,500 | from $12,000 |
| Proton-beam therapy | from $36,500 | from $70,000 | from $80,000 |
| NanoKnife | from $22,500 | from $9,500 | from $25,000 |
Nearly 10,000 cryosurgeries performed – Prof. Niu Lizhi is a pioneer in minimally invasive cancer treatments at Fuda Cancer Hospital.
Dr. Liuying directs the Oncology Ward at Jinshazhou Hospital in Guangzhou. She specializes in minimally invasive ablation for liver, lung, and colorectal cancers. Her primary focus includes hepatocellular carcinoma and melanoma liver metastasis. Dr. Liuying contributed to the national expert consensus on thermal ablation for lung tumors.
Professor Liang Xiaoxiao is the Department Director and Chief Physician in Neurorehabilitation. She holds a master’s degree in neurology. She is skilled in neuromodulation for disorders of consciousness, cognition, and movement. Her focus includes cases from cerebrovascular disease, Parkinson’s disease, and related conditions. She also performs ultrasound-guided botulinum toxin injections for blepharospasm, hemifacial spasm, limb spasticity, sialorrhea, and neuralgia.
Accreditations and roles: Member of the Neurorehabilitation, Cognitive Disorder Rehabilitation, and Craniocerebral Trauma Rehabilitation Committees of the Chinese Association of Rehabilitation Medicine. Standing Member of the Cognitive Disorder Rehabilitation Committee of the Fujian Association of Rehabilitation Medicine. Vice Chair of the Dementia and Cognitive Disorder Committee of the Xiamen Preventive Medicine Association. Vice President of the Parkinson’s Disease and Movement Disorders Committee of the Xiamen Medical Doctor Association. Standing Member of the Neuromodulation Committee of the Xiamen Medical Doctor Association. Recipient of the Most Beautiful Physician of Xiamen City (2024).
Dr. Liu Shi Xin is the Vice Chairman of the Radiation Oncology Branch of the Chinese Medical Association. He serves as the Discipline Leader of the Oncology Center at Xiamen Humanity Hospital. Dr. Liu specializes in precision radiotherapy for thoracic and abdominal cancers. He is a recipient of the State Council Special Government Allowance for his medical contributions.
Written by Halina Shubala
Chinese medical centers treat liver cancer using a multimodal approach governed by the China Liver Cancer staging system. Primary options include advanced surgical resection, liver transplantation, and interventional therapies like TACE. Specialized facilities also integrate immunotherapy with proprietary techniques like NanoKnife and cryosurgery for complex cases.
Bookimed Expert Insight: Data from leading facilities like Fuda Cancer Hospital reveals a significant trend toward combining multiple minimally invasive therapies rather than relying on standard chemotherapy. For instance, Dr. Niu Lizhi has performed over 10,000 cryosurgery procedures. This high volume allows centers to offer aggressive `triple-threat` protocols—combining cryodestruction, NanoKnife, and vascular interventional therapy—even for patients previously considered inoperable.
Patient Consensus: Patients often note that Chinese protocols are more aggressive, frequently combining surgery with immediate TACE or immunotherapy. Many emphasize the importance of regular AFP monitoring post-treatment to manage the risk of recurrence effectively.
Liver cancer survival in China depends largely on the cancer stage at diagnosis. Early-stage patients achieve a 48.1% five-year survival rate. Modern surgical interventions for Stage Ia cases reach 77.4% survival. These specialized centers utilize JCI-accredited facilities and minimally invasive techniques to improve clinical outcomes.
Bookimed Expert Insight: Advanced technology availability significantly influences specialized treatment paths in Guangzhou. Dr. Niu Lizhi at Fuda Cancer Hospital has performed nearly 10,000 cryosurgeries and 500 NanoKnife procedures. This high volume of specialized, minimally invasive operations is a key differentiator for patients seeking alternatives to traditional resection.
Patient Consensus: Patients note the value of accessing 10+ types of minimally invasive therapies under one roof. They often highlight that clear communication about modern equipment like the CyberKnife M6 system helped them feel more confident.
VG161 and Reduce and Remove strategies are available in China through clinical trials and specialized medical zones. These innovative therapies treat advanced liver cancer by stimulating immune rejection. Access is typically managed via specific research institutions or the Boao Lecheng Pilot Zone in Hainan.
Bookimed Expert Insight: While innovative trials make headlines, established clinics like Fuda Cancer Hospital provide immediate access to proven alternatives. Specialized surgeons like Dr. Niu Lizhi have performed over 10,000 cryosurgeries for advanced stages. This high volume often results in better practical outcomes than waiting for experimental trial openings. If you seek specialized care, focus on clinics with JCI accreditation and documented procedure counts.
Patient Consensus: Patients value the availability of minimally invasive options that serve as alternatives to traditional chemotherapy. Many emphasize the importance of having international departments to help manage the complex paperwork required for trial entry.
Chinese oncology centers incorporate Traditional Chinese Medicine (TCM) as a standardized adjuvant therapy for liver cancer. Doctors use herbal formulas and integrative protocols to enhance the efficacy of transarterial chemoembolization (TACE) and chemotherapy. This combined approach improves 1-year survival rates and reduces systemic toxicity.
Bookimed Expert Insight: Leading facilities like Jinshazhou Hospital of Guangzhou University of Chinese Medicine bridge the gap between ancient and modern care. Our data shows they house advanced technology like the CyberKnife M6 system specifically within traditional medicine universities. This indicates that TCM is not a secondary choice in China but is deeply integrated into high-tech oncology departments. Patients can access specialized radiosurgery and TCM-based recovery protocols within the same hospital environment.
Patient Consensus: Patients note that TCM-Western protocols are often bundled together in Chinese hospitals to stabilize liver enzymes. Many emphasize using herbs for symptom relief like fatigue but warn against delaying surgery in favor of TCM alone.
International patients choose China for liver cancer treatment due to unmatched procedural volume and rapid access to advanced therapies. Chinese centers treat approximately 50% of global hepatocellular carcinoma cases. This vast experience leads to specialized mastery in cryosurgery, NanoKnife, and CyberKnife M6 technologies with minimal waiting times.
Bookimed Expert Insight: China’s top oncology centers provide a unique speed advantage. Our data shows hospitals like Xiamen Humanity serve over 1,000,000 patients annually. This massive scale allows for a 72-hour diagnostic-to-treatment pipeline. While Western waitlists can take weeks, Chinese centers often start immunotherapy or ablation within days of arrival.
Patient Consensus: Patients note that the same-day consultation process is life-saving when facing aggressive tumors. Many emphasize that local surgeons handle thousands of resections yearly, providing a level of hands-on experience rarely found elsewhere.
Chinese specialised centres reach 60–70% 5-year survival rates for early-stage liver cancer. Outcomes depend on the stage. Stage I has 48.1% 5-year survival, while paediatric liver transplants exceed 90%. Hospitals use cryosurgery, NanoKnife, and CyberKnife to treat complex cases.
Bookimed Expert Insight: Success in Chinese oncology is often driven by massive procedure volumes and focused technology. Fuda Cancer Hospital serves over 30,000 patients from 100+ countries. It uses 10+ types of minimally invasive therapies. High-volume surgeons like Dr Niu Lizhi, with 500+ NanoKnife procedures, offer rare expertise. Australian patients should focus on centres matching their specific stage with these high-frequency specialists.
Patient Consensus: Patients emphasise that access speed and a surgeon’s willingness to operate are vital factors. Discussions note that major cancer centres offer quicker access to locoregional therapies and ablation techniques.
China offers specialised liver cancer treatments including Boron Neutron Capture Therapy (BNCT), NanoKnife irreversible electroporation, and cryosurgery. These methods often treat inoperable tumours or advanced cases. Major JCI-accredited centres in Guangzhou and Xiamen provide these specific interventional oncology techniques.
Bookimed Expert Insight: China's high liver cancer patient volume drives rapid adoption of niche technologies. Xiamen Humanity Hospital serves 1,000,000 patients annually. Fuda Cancer Hospital specialises in minimally invasive therapies instead of standard chemotherapy. These procedures are often part of a multi-modal plan. Patients should look for specialists like Prof. Dr Liu Shi Xin. He holds leadership roles in national radiation oncology committees, which helps maintain rigorous clinical standards.
Patient Consensus: Patients find that major Chinese centres combine standard oncology with specialised therapies. It is vital to confirm if a treatment is standard-of-care or experimental. Bringing pathology and imaging results in English helps bridge language gaps. This also ensures accurate staging before travel to China.
Chinese oncology centres prioritise minimally invasive interventional radiology and radiotherapy for liver cancer. These facilities often combine Transarterial Chemoembolisation (TACE) with immunotherapy for intermediate and advanced stages. Specialised clinics, such as JCI-accredited Fuda Cancer Hospital, focus on ablative techniques and therapies like NanoKnife.
Bookimed Expert Insight: Many countries focus on surgery. However, Chinese centres like Fuda Cancer Hospital specialise in late-stage cases. They use over 10 types of minimally invasive therapies. Dr Niu Lizhi alone has performed nearly 10,000 cryosurgeries. This high volume makes China a hub for patients seeking alternatives to traditional surgery.
Patient Consensus: Patients in China often receive surgical offers for operable tumours. They find TACE and immunotherapy are common for more complex cases. They also note that Traditional Chinese Medicine is frequently available as supportive care alongside standard oncology treatments.
China hosts multiple international facilities specialising in liver cancer, providing therapies like NanoKnife and CyberKnife. JCI-accredited centres in Guangzhou and Xiamen offer multilingual support and dedicated international departments. These hospitals serve thousands of global patients with minimally invasive technology. Most facilities provide end-to-end logistics for foreign nationals.
Bookimed Expert Insight: While many centres claim international status, true expertise is found in high-volume hubs like Guangzhou. Fuda Cancer Hospital has served patients from over 100 countries. It showcases a rare level of cultural and clinical experience. This high international caseload often leads to more streamlined billing and smoother visa support.
Patient Consensus: Patients recommend confirming English-speaking oncology support before travelling. They should also verify the presence of a dedicated international office. Translating pathology reports and scans beforehand helps speed up the assessment. This also reduces communication delays in China.